title: Biochemical evidence of thiamine depletion during the Cuban neuropathy epidemic, 1992-1993.
abstract: During an epidemic outbreak of neuropathy in Cuba during 1992-1993, blood and urine samples were collected from 107 persons with confirmed neuropathy, from 106 control subjects without clinical abnormality who were broadly matched with the affected persons by age and domicile, and from 537 unmatched subjects, also free from clinical abnormality. The unmatched subjects lived in two locations in Cuba; at each location they were drawn from two age ranges: 11-15-y-old secondary school students and 16-64-y-old adults. Measurements of urinary thiamine and blood transketolase and its activation with thiamine pyrophosphate were made. For the neuropathy subjects, these measurements were repeated after 3 wk of rehabilitation. All groups showed biochemical evidence of thiamine depletion affecting 30-70% of their members, which is a high prevalence. Severity of biochemical depletion was, however, no greater in the neuropathy subjects than in the control subjects (P > 0.05). However, it was greater in Pinar del Rio, where the incidence of disease was higher, than in the city of Havana, where less disease was seen. Although the majority of the affected subjects responded biochemically to a daily oral multivitamin supplement containing thiamine (P < 0.001), in some cases normal biochemical status was not achieved even after 3 wk of intensive treatment. In the affected group, thiamine status was inversely correlated with the amount of alcohol consumed (P = 0.007). Thiamine status at the outset was correlated with clinical outcome after treatment. Although neither thiamine depletion nor alcohol abuse were likely to have been the sole cause of the neuropathy epidemic, they may have been contributory factors. Thiamine supplementation or food fortification may therefore be necessary in Cuba.
authors.affiliation: Institute of Nutrition and Food Hygiene, Havana.
authors.forename: C
authors.initials: C
authors.lastname: Macias-Matos
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez-Ojea
authors.forename: N
authors.initials: N
authors.lastname: Chi
authors.forename: S
authors.initials: S
authors.lastname: Jimenez
authors.forename: D
authors.initials: D
authors.lastname: Zulueta
authors.forename: C J
authors.initials: CJ
authors.lastname: Bates
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000428:Alcohol Drinking; D002648:Child; D003462:Cuba / Q000453:epidemiology; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009901:Optic Nerve Diseases / Q000453:epidemiology* / Q000378:metabolism*; D010523:Peripheral Nervous System Diseases / Q000453:epidemiology* / Q000378:metabolism*; D015995:Prevalence; D013831:Thiamine / Q000627:therapeutic use; D013832:Thiamine Deficiency / Q000188:drug therapy / Q000453:epidemiology* / Q000378:metabolism*; D013835:Thiamine Pyrophosphate / Q000652:urine; D014174:Transketolase / Q000097:blood
chemical_list: D014174:Transketolase; D013835:Thiamine Pyrophosphate; D013831:Thiamine